share_log

Eiger BioPharmaceuticals | 10-K: FY2022 Annual Report

SEC announcement ·  Mar 16, 2023 18:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more